Resveratrol confers resistance against taxol via induction of cell cycle arrest in human cancer cell lines
Authors:
- 3 November 2010
- journal article
- research article
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 54 (11) , 1574-1584
Abstract
Resveratrol, which is highly concentrated in the skin of grapes and is abundant in red wine, has been demonstrated to account for several beneficial properties, including antioxidant, anticoagulant, anti‐inflammatory and anticancer effects. Taxol is a microtubule‐stabilizing drug that has been extensively used as effective chemotherapeutic agents in the treatment of solid tumors. Here, we investigated whether the combination of the two compounds would yield increased antitumor efficacy in human cancer cells. Unexpectedly, resveratrol effectively prevented tumor cell death induced by taxol in 5637 bladder cancer cells. This pronounced antagonistic function of resveratrol against taxol was associated with changes in multiple signal transduction pathways, but not with tubulin polymerization. Importantly, cell cycle analysis showed that resveratrol prevented the cells from entering into mitosis, the phase in which taxol exerts its action. Furthermore, resveratrol blocked the cytotoxic effects of vinblastine but not cisplatin in 5637 cells. Interestingly, resveratrol pre‐treatment followed by taxol resulted in synergistic cytotoxicity. Finally, we extended our studies to various human cancer cell lines. Taken together, our results indicate that resveratrol may have the potential to negate the therapeutic efficacy of taxol and suggest that consumption of resveratrol‐related products may be contraindicated during cancer therapy with taxol.Keywords
This publication has 30 references indexed in Scilit:
- Resveratrol: From Basic Science to the ClinicCell Cycle, 2007
- Cytoskeleton and paclitaxel sensitivity in breast cancer: The role of β‐tubulinsInternational Journal of Cancer, 2007
- Therapeutic potential of resveratrol: the in vivo evidenceNature Reviews Drug Discovery, 2006
- Resveratrol interference with the cell cycle protects human neuroblastoma SH-SY5Y cell from paclitaxel-induced apoptosisNeurochemistry International, 2005
- Sensitization for anticancer drug-induced apoptosis by the chemopreventive agent resveratrolOncogene, 2004
- PI3K/Akt and apoptosis: size mattersOncogene, 2003
- Phosphorylation on Tyrosine-15 of p34Cdc2 by ErbB2 Inhibits p34Cdc2 Activation and Is Involved in Resistance to Taxol-Induced ApoptosisMolecular Cell, 2002
- NF-κB in cancer: from innocent bystander to major culpritNature Reviews Cancer, 2002
- Multidrug resistance in cancer: role of ATP–dependent transportersNature Reviews Cancer, 2002
- Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from GrapesScience, 1997